Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Open access
Boelaert, J R, de Locht, M, Van Cutsem, J, Kerrels, V, Cantinieaux, B, Verdonck, A, Van Landuyt, H W, Schneider, Y J · 1993 · Journal of Clinical Investigation

Abstract

This study investigates the pathophysiology of mucormycosis caused by Rhizopus, which has been reported in 46 dialysis patients, while treated with deferoxamine (DFO). This drug aggravates mucormycosis, which we experimentally induced in guinea pigs and which lead to a shortened animal survival (P < or = 0.01). The drug's effect on Rhizopus is not mediated through the polymorphonuclear cells. Fe.DFO, the iron chelate of DFO, abolishes the fungistatic effect of serum on Rhizopus and increases the in vitro growth of the fungus (P < or = 0.0001). This effect is present at Fe.DFO concentrations > or = 0.01 microM, at which fungal uptake of radioiron from 55Fe.DFO is observed. A 1,000-fold higher concentration of iron citrate is required to achieve a similar rate of radioiron uptake and of in vitro growth stimulation as observed with Fe.DFO. These in vitro effects of Fe.DFO (1 microM) in serum on radioiron uptake and on growth stimulation are more striking for Rhizopus than for Aspergillus fumigatus and are practically absent for Candida albicans. For these three fungal species, the rates of radioiron uptake from 55Fe.DFO and of growth stimulation in the presence of Fe.DFO in serum are directly related (r = 0.886). These results underscore the major role of Fe.DFO in the pathogenesis of DFO-related mucormycosis. Pharmacokinetic changes in uremia lead to a prolonged accumulation of Fe.DFO after DFO administration, which helps explain the increased sensitivity of dialysis patients to DFO-related mucormycosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci116419

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 36 · Cited by 340

Research works printed but not linked: 4

  1. Boelaert, J. R., M. de Locht, and J. Van Cutsem. 1993. Desferrioxamine and microorganisms: studies on in vitro growth and on experimental infections. A review. Rev. Med. Microbiol. In press.
  2. Van Cutsem, J., J. Fransen, and P. A. J. Janssen. 1985. Animal models for systemic dermatophyte and Candida infection with dissemination to the skin. In Models in Dermatology. H. I. Maibach and N. J. Lowe, editors. Vol. 1. Karger, Basel. 196-201.
  3. Van Cutsem, J., F. Van Gerven, J. Fransen, and P. A. J. Janssen. 1987. New guinea-pig model ofdisseminated cryptococcosis associated with dermatro- pism. In Models in Dermatology. H. I. Maibach and N. J. Lowe, editors. Vol. 3. Karger, Basel. 180-189.
  4. Artis, W. M., F. Rastinejad, R. L. Duncan, T. C. Granade, and M. Holz- berg. 1985. Mechanism ofhost defense against fungus infections: transferrin, iron and fungal siderophores. In Filamentous microorganisms. T. Arai, editor. Japan Scientific Societies Press, Tokyo. 231-245.

Metadata

Authors
Boelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J.
Affiliations
  • Janssen (Belgium) (BE)
  • AZ Sint-Jan (BE)
Venue
Journal of Clinical Investigation
Published
1993-05-01
Volume
91
Issue
5
Pages
1979-1986
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2159892946
Cited by
340
References
36
Citations by year
2026: 3 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 26 · 2021: 26 · 2020: 6 · 2019: 12 · 2018: 10 · 2017: 15 · 2016: 7 · 2015: 10 · 2014: 14 · 2013: 18 · 2012: 17
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders
Université Catholique de Louvain
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Mycology
Keywords
mucormycosis, deferoxamine, Rhizopus, iron chelates, fungal growth stimulation, dialysis patients, uremia, Aspergillus fumigatus, Candida albicans, guinea pig model, pathogenesis
MeSH terms
Animals, Blood Physiological Phenomena, Candida albicans, Candidiasis, Deferoxamine, Guinea Pigs, Renal Dialysis, Humans, Mucormycosis, Neutrophils, Rhizopus, Spores, Fungal, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. https://app.cochat.ai/papers/10.1172/jci116419
The paper
Boelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J. (1993). Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. Journal of Clinical Investigation. https://doi.org/10.1172/jci116419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.